A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)
Clinical trial NCT02420821 · COMPLETED
Trial details
- NCT number
- NCT02420821
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-20
- Primary completion
- 2020-02-14
- Enrollment
- 915
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.